A randomized double-blind controlled trial of two different doses of self-administered vaginal misoprostol for successful copper intrauterine device insertion
Objective: The current study aims to compare the efficacy and safety of 200 mcg versus 400 mcg vaginal misoprostol administered 3 h prior to intrauterine device (IUD) insertion in parous women. Study design: A randomized double-blind controlled trial. Setting: Women’s Health Hospital, Assiut, Egypt....
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2017-12-01
|
Series: | Middle East Fertility Society Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S111056901730016X |